Company: BNBX
Filing Date: 2025-06-17
Form Type: 8-K
Source: 0001104659-25-060258
Chunk: 1

Company: BNB PLUS CORP.
Filing Date: 2025-06-17
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                      
         10.1      Separation Agreement, dated June 16, 2025, by and between the Company and Dr. James A. Hayward.  
         99.1      Press Release, dated June 17, 2025.                                                              
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                     

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: June 17, 2025      APPLIED DNA SCIENCES, INC.                               
 ────────────────────────────────────────────────────────────────────────────────────
                           By:                             /s/ Beth Jantzen         
                           Name:                           Beth Jantzen             
                           Title:                          Chief Financial Officer